Literature DB >> 28123815

The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China.

Meng-Na Lv1, Hong Zhang2, Yi Shu1, Shan Chen3, Yuan-Yuan Hu4, Min Zhou5.   

Abstract

Background" Autism spectrum disorder (ASD) is a serious neurodevelopmental disorder that impairs a child's ability to communicate with others. It also includes restricted repetitive behaviors, interests and activities. Symptoms manifest before the age of 3. In the previous studies, we found structural abnormalities of the temporal lobe cortex. High spine densities were most commonly found in ASD subjects with lower levels of cognitive functioning. In the present study, we retrospectively analyzed medical records in relation to the neonatal levels of total serum bilirubin (TSB), neuron-specific enolase (NSE), creatine kinase brain band isoenzyme (CK-BB), and neonatal behavior in ASD patients from Southern China.
METHODS: A total of 80 patients with ASD (ASD group) were screened for this retrospective study. Among them, 34 were low-functioning ASD (L-ASD group) and 46 were high-functioning ASD (H-ASD group). Identification of the ASD cases was confirmed with a Revised Autism Diagnostic Inventory. For comparison with ASD cases, 80 normal neonates (control group) were selected from the same period. Biochemical parameters, including TSB, NSE and CK-BB in the neonatal period and medical records on neonatal behavior were collected.
RESULTS: The levels of serum TSB, NSE and CK-BB in the ASD group were significantly higher when compared with those from the control group (P < 0.01, or P < 0.05). The amounts of serum TSB, NSE and CK-BB in the L-ASD group were significantly higher when compared with those in the H-ASD group (P < 0.01, or P < 0.05). The Neonatal Behavioral Assessment Scale (NBAS) scores in the ASD group were significantly lower than that in the control group (P < 0.05). Likewise, the NBAS scores in the L-ASD group were significantly lower than that in the H-ASD group (P < 0.05). There was no association between serum TSB, NSE, CK-BB and NBAS scores (P > 0.05) in the ASD group.
CONCLUSIONS: The neonatal levels of TSB, NSE and CK-BB in ASD from Southern China were significantly higher than those of healthy controls. These findings need to be investigated thoroughly by future studies with large sample.

Entities:  

Keywords:  Autism spectrum disorder; Creatine kinase brain band isoenzyme; Neonatal behavioral assessment; Neuron-specific enolase; Total serum bilirubin

Year:  2016        PMID: 28123815      PMCID: PMC5017591          DOI: 10.1515/tnsci-2016-0002

Source DB:  PubMed          Journal:  Transl Neurosci        ISSN: 2081-6936            Impact factor:   1.757


  30 in total

Review 1.  Is neonatal jaundice associated with Autism Spectrum Disorders: a systematic review.

Authors:  Sanjiv B Amin; Tristram Smith; Hongyue Wang
Journal:  J Autism Dev Disord       Date:  2011-11

2.  Minicolumnar abnormalities in autism.

Authors:  Manuel F Casanova; Imke A J van Kooten; Andrew E Switala; Herman van Engeland; Helmut Heinsen; Harry W M Steinbusch; Patrick R Hof; Juan Trippe; Janet Stone; Christoph Schmitz
Journal:  Acta Neuropathol       Date:  2006-07-04       Impact factor: 17.088

Review 3.  Neuropathology of infantile autism.

Authors:  T L Kemper; M Bauman
Journal:  J Neuropathol Exp Neurol       Date:  1998-07       Impact factor: 3.685

4.  Pervasive developmental disorders in preschool children: confirmation of high prevalence.

Authors:  Suniti Chakrabarti; Eric Fombonne
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

5.  Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort.

Authors:  Stephanie M Engel; Gertrud S Berkowitz; Dana B Barr; Susan L Teitelbaum; Jodi Siskind; Stefanie J Meisel; James G Wetmur; Mary S Wolff
Journal:  Am J Epidemiol       Date:  2007-04-03       Impact factor: 4.897

6.  Histological and magnetic resonance imaging assessment of cortical layering and thickness in autism spectrum disorders.

Authors:  Jeffrey J Hutsler; Tiffany Love; Hong Zhang
Journal:  Biol Psychiatry       Date:  2006-04-03       Impact factor: 13.382

7.  Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of >or=325 micromol/L (>or=19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000.

Authors:  Krista A Jangaard; Deshayne B Fell; Linda Dodds; Alexander C Allen
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

8.  Metabolic biomarkers related to energy metabolism in Saudi autistic children.

Authors:  O A Al-Mosalem; A El-Ansary; O Attas; L Al-Ayadhi
Journal:  Clin Biochem       Date:  2009-04-17       Impact factor: 3.281

9.  Neonatal jaundice: a risk factor for infantile autism?

Authors:  Rikke Damkjaer Maimburg; Michael Vaeth; Diana Elizabeth Schendel; Bodil Hammer Bech; Jørn Olsen; Poul Thorsen
Journal:  Paediatr Perinat Epidemiol       Date:  2008-11       Impact factor: 3.980

Review 10.  Genetic aspects of autism spectrum disorders: insights from animal models.

Authors:  Swati Banerjee; Maeveen Riordan; Manzoor A Bhat
Journal:  Front Cell Neurosci       Date:  2014-02-24       Impact factor: 5.505

View more
  3 in total

1.  High Serum Levels of Serum 100 Beta Protein, Neuron-specific Enolase, Tau, Active Caspase-3, M30 and M65 in Children with Autism Spectrum Disorders.

Authors:  Hamza Ayaydın; Adnan Kirmit; Hakim Çelik; İsmail Akaltun; İsmail Koyuncu; Şermin Bilgen Ulgar
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

2.  The level of GNE and its relationship with behavioral phenotypes in children with autism spectrum disorder.

Authors:  Xiaolei Yang; Hongjie Li; Jie Ge; Hong Chao; Gang Li; Zhongguang Zhou; Jicheng Liu
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

Review 3.  Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.

Authors:  Shannon Rose; Dmitriy M Niyazov; Daniel A Rossignol; Michael Goldenthal; Stephen G Kahler; Richard E Frye
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.